F144-0427 Screening compound: 2-[3-(4-{[(2-methoxyethyl)carbamoyl]methyl}phenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl]-N-(2-phenylethyl)acetamide

F144-0427 Screening compound: 2-[3-(4-{[(2-methoxyethyl)carbamoyl]methyl}phenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl]-N-(2-phenylethyl)acetamide
F144-0427 Screening compound: 2-[3-(4-{[(2-methoxyethyl)carbamoyl]methyl}phenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl]-N-(2-phenylethyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F144-0427
2-[3-(4-{[(2-methoxyethyl)carbamoyl]methyl}phenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl]-N-(2-phenylethyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F144-0427

Molecular Formula

C29H30N4O5 (C29 H30 N4 O5)

Compound Name

2-[3-(4-{[(2-methoxyethyl)carbamoyl]methyl}phenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl]-N-(2-phenylethyl)acetamide

IUPAC name

2-[3-(4-{[(2-methoxyethyl)carbamoyl]methyl}phenyl)-24-dioxo-1234-tetrahydroquinazolin-1-yl]-N-(2-phenylethyl)acetamide

SMILES

COCCNC(Cc(cc1)ccc1N(C(c(cccc1)c1N1CC(NCCc2ccccc2)=O)=O)C1=O)=O

InChI

InChI=1S/C29H30N4O5/c1-38-18-17-31-26(34)19-22-11-13-23(14-12-22)33-28(36)24-9-5-6-10-25(24)32(29(33)37)20-27(35)30-16-15-21-7-3-2-4-8-21/h2-14H,15-20H2,1H3,(H,30,35)(H,31,34)

InChI Key

PBSUNGMVNIYRDX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27104572

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

514.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.971

Distribution Coefficient, logD

0.971

Water Solubility, LogSw

-2.37

Polar Surface Area

87.624

Acid Dissociation Constant (pKa)

14.03

Base Dissociation Constant (pKb)

4.84

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.10

F144-0427 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F144-0427 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F144-0427?
Check Price and Availability of F144-0427, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F144-0427 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F144-0427
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F144-0427
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F144-0427 available by request